Tonix Pharmaceuticals names CEO's son as strategy chief
Go back to Tonix Pharmaceuticals names CEO's son as strategy chief| TONIX PHARM HLDG (NASDAQ: TNXP) | Delayed: 5.17 +0.07 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.10 | 52 Week High | $7.95 | |||
| Open | $5.10 | 52 Week Low | $0.40 | |||
| Day High | $5.22 | P/E | N/A | |||
| Day Low | $5.04 | EPS | $-5.33 | |||
| Volume | 148,106 | |||||



